Form 8-K - Current report:
SEC Accession No. 0001193125-25-005848
Filing Date
2025-01-14
Accepted
2025-01-14 09:15:37
Documents
56
Period of Report
2025-01-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d917187d8k.htm   iXBRL 8-K 29195
2 EX-99.1 d917187dex991.htm EX-99.1 23140
3 EX-99.2 d917187dex992.htm EX-99.2 53442
7 GRAPHIC g917187ex99_2p10g1.jpg GRAPHIC 408680
8 GRAPHIC g917187ex99_2p11g1.jpg GRAPHIC 424103
9 GRAPHIC g917187ex99_2p12g1.jpg GRAPHIC 326996
10 GRAPHIC g917187ex99_2p13g1.jpg GRAPHIC 417587
11 GRAPHIC g917187ex99_2p14g1.jpg GRAPHIC 383092
12 GRAPHIC g917187ex99_2p15g1.jpg GRAPHIC 414449
13 GRAPHIC g917187ex99_2p16g1.jpg GRAPHIC 404268
14 GRAPHIC g917187ex99_2p17g1.jpg GRAPHIC 382035
15 GRAPHIC g917187ex99_2p18g1.jpg GRAPHIC 239060
16 GRAPHIC g917187ex99_2p19g1.jpg GRAPHIC 325328
17 GRAPHIC g917187ex99_2p1g1.jpg GRAPHIC 297442
18 GRAPHIC g917187ex99_2p20g1.jpg GRAPHIC 275728
19 GRAPHIC g917187ex99_2p21g1.jpg GRAPHIC 413080
20 GRAPHIC g917187ex99_2p22g1.jpg GRAPHIC 313748
21 GRAPHIC g917187ex99_2p23g1.jpg GRAPHIC 266445
22 GRAPHIC g917187ex99_2p24g1.jpg GRAPHIC 283014
23 GRAPHIC g917187ex99_2p25g1.jpg GRAPHIC 297405
24 GRAPHIC g917187ex99_2p26g1.jpg GRAPHIC 350972
25 GRAPHIC g917187ex99_2p27g1.jpg GRAPHIC 410361
26 GRAPHIC g917187ex99_2p28g1.jpg GRAPHIC 348045
27 GRAPHIC g917187ex99_2p29g1.jpg GRAPHIC 421215
28 GRAPHIC g917187ex99_2p2g1.jpg GRAPHIC 787686
29 GRAPHIC g917187ex99_2p30g1.jpg GRAPHIC 370764
30 GRAPHIC g917187ex99_2p31g1.jpg GRAPHIC 454137
31 GRAPHIC g917187ex99_2p32g1.jpg GRAPHIC 379615
32 GRAPHIC g917187ex99_2p33g1.jpg GRAPHIC 254521
33 GRAPHIC g917187ex99_2p34g1.jpg GRAPHIC 430545
34 GRAPHIC g917187ex99_2p35g1.jpg GRAPHIC 426015
35 GRAPHIC g917187ex99_2p36g1.jpg GRAPHIC 334659
36 GRAPHIC g917187ex99_2p37g1.jpg GRAPHIC 364430
37 GRAPHIC g917187ex99_2p38g1.jpg GRAPHIC 545202
38 GRAPHIC g917187ex99_2p39g1.jpg GRAPHIC 342909
39 GRAPHIC g917187ex99_2p3g1.jpg GRAPHIC 483050
40 GRAPHIC g917187ex99_2p40g1.jpg GRAPHIC 387545
41 GRAPHIC g917187ex99_2p4g1.jpg GRAPHIC 283561
42 GRAPHIC g917187ex99_2p5g1.jpg GRAPHIC 384729
43 GRAPHIC g917187ex99_2p6g1.jpg GRAPHIC 219347
44 GRAPHIC g917187ex99_2p7g1.jpg GRAPHIC 344615
45 GRAPHIC g917187ex99_2p8g1.jpg GRAPHIC 351570
46 GRAPHIC g917187ex99_2p9g1.jpg GRAPHIC 231339
47 GRAPHIC g917187g0114103047141.jpg GRAPHIC 4263
  Complete submission text file 0001193125-25-005848.txt   20624476

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20250114.xsd EX-101.SCH 2845
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20250114_lab.xml EX-101.LAB 17995
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20250114_pre.xml EX-101.PRE 11258
58 EXTRACTED XBRL INSTANCE DOCUMENT d917187d8k_htm.xml XML 3642
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

EIN.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 25527902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)